PMPRB Hearing Panel issues decision in Procysbi case
Imported from official source
A Patented Medicine Prices Review Board (PMPRB) Hearing Panel issued its decision relating to the medicine Procysbi, manufactured and marketed in Canada by Horizon Pharma.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
7b760be32fc4909aa38ca7ffafbe4842- All versions
- Revision history